Patients with cancer are frequently exposed to risk of renal injuries associated with disease-
related or iatrogenic causes. Nephrotoxicity is a potential adverse effect of anti-cancer …

Kidney injury caused by anticancer agents is a common problem that can interfere with and
affect the dose intensity of anticancer therapy, thus restricting patient survival. Recent …

It has been estimated that nearly 80% of anticancer drug-treated patients receive potentially
nephrotoxic drugs, while the kidneys play a central role in the excretion of anticancer drugs …

Anticancer drug-induced kidney disease is a problem commonly encountered by
nephrologists. The number of medications employed by oncologists causing acute and …

Nephrotoxicity is one of the most important complications in cancer patients. In particular,
acute kidney injury (AKI) is known to be associated with discontinuing effective oncological …

Targeted therapies that act via unique molecular pathways and interfere with cancer cell
growth and tumor progression have dramatically changed the cancer treatment paradigm …

Anticancer drug nephrotoxicity is an important and increasing adverse drug event that limits
the efficacy of cancer treatment. The kidney is an important elimination pathway for many …

Over the past few decades, significant progress has been made in the development of drugs
to combat cancer. It is unfortunate that these drugs can also lead to various kidney injuries …

Nephrotoxicity is an inherent adverse effect of certain anticancer drugs and may result in a
variety of functional consequences that include any combination of glomerular or tubular …

New anticancer medications are rapidly entering the clinical arena offering patients with
previously resistant cancers the promise of more effective therapies capable of extending …